2 results
Approved WMOWill not start
The primary objectives of the study are to:• Evaluate efficacy of 24 weeks treatment with RO4917838 in the PANSS negative symptom factor score in patients with persistent, predominant negative symptoms of schizophrenia treated with antipsychotics.•…
Approved WMOCompleted
To study the effects of ARA290 on the cognitive and neural processing of emotions in healthy volunteers 7 days post-administration.